Volume 22 - Issue 4 - April, 2010
Original Contribution
03/25/2010
Arton Beqiri, MD; Sergio Berti, MD; Cataldo Palmieri, MD; Marcello Ravani, MD; Giuseppe Trianni, MD; Jacopo Gianetti, MD, PhD; Marco Vaghetti, MD; Antonio Rizza, MD; Umberto Paradossi, MD
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up
ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs....
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up
ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs....
Drug-Eluting Stents versus...
03/25/2010
Journal of Invasive Cardiology
Commentary
03/25/2010
Mohit D. Gupta, MD, DM; Matthew J. Budoff, MD
In the past few years, the use of drug-eluting stents (DES) has had a significant impact on the practice of interventional cardiology. The introduction of DES followed the same course as any newly introduced technique, with the initial period...
In the past few years, the use of drug-eluting stents (DES) has had a significant impact on the practice of interventional cardiology. The introduction of DES followed the same course as any newly introduced technique, with the initial period...
In the past few years, the use...
03/25/2010
Journal of Invasive Cardiology
03/26/2010
Gian Paolo Ussia, MD; Davide Capodanno, MD; Corrado Tamburino, MD, PhD, FESC, FSCAI; Marco Barbanti, MD; Marilena Scarabelli, MD; Sebastiano Imme, MD; Valeria Cammalleri, MD; Massimiliano Mule, MD; Anna Pistritto, MD; Patrizia Aruta, MD
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in...
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in...
ABSTRACT: Objectives. To...
03/26/2010
Journal of Invasive Cardiology
Commentary
03/26/2010
Peter C. Block, MD
In this issue of the Journal, Ussia and colleagues discuss their experience with using balloon aortic valvuloplasty (BAV) as a “bridge” to transcatheter aortic valve implantation (TAVI) in patients at high risk for TAVI.1 They chose high-risk...
In this issue of the Journal, Ussia and colleagues discuss their experience with using balloon aortic valvuloplasty (BAV) as a “bridge” to transcatheter aortic valve implantation (TAVI) in patients at high risk for TAVI.1 They chose high-risk...
In this issue of the Journal,...
03/26/2010
Journal of Invasive Cardiology
Original Contribution
03/31/2010
Ramin Ebrahimi, MD; Shahdad Azmoon, MD; Craig Hjemdahl-Monsen, MD; Joseph Vozzolo, MD; Archana Rajdev, MD; Kumar Kalapatapu, MD; Wilbert S. Aronow, MD, AGSF; Anthony L. Pucillo, MD; Jae H. Ro, MD
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device
ABSTRACT: We investigated the prevalence of vascular complications after...
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device
ABSTRACT: We investigated the prevalence of vascular complications after...
Vascular Complications after...
03/31/2010
Journal of Invasive Cardiology
Commentary
03/31/2010
Jaime Ghitelman, MD; Lawrence A. Garcia, MD, FACC, FAHA
Vascular closure devices (VCDs) became available to the interventional cardiology community in the mid-1990s. VCDs were initially created to treat the high rates of access-site bleeding associated with percutaneous coronary intervention (PCI)...
Vascular closure devices (VCDs) became available to the interventional cardiology community in the mid-1990s. VCDs were initially created to treat the high rates of access-site bleeding associated with percutaneous coronary intervention (PCI)...
Vascular closure devices (VCDs)...
03/31/2010
Journal of Invasive Cardiology
Original Contribution
03/31/2010
Christian Jung, MD, PhD; Ziyad M. Hijazi, MD, MPH; Horst Sievert, MD, FESC, FACC, FSCAI; Alexander Lauten, MD; Hans-Rainer Figulla, MD; Markus Ferrari, MD; Florian Krizanic, MD; Dietrich Pfeiffer, MD; Thomas Konorza, MD
ABSTRACT: Background. We investigated the safety, feasibility and efficacy of the Occlutech® devices for patent foramen ovale (PFO) and atrial septal defect (ASD) closure in a prospective trial. Methods. The retention discs of the PFO device...
ABSTRACT: Background. We investigated the safety, feasibility and efficacy of the Occlutech® devices for patent foramen ovale (PFO) and atrial septal defect (ASD) closure in a prospective trial. Methods. The retention discs of the PFO device...
ABSTRACT: Background. We...
03/31/2010
Journal of Invasive Cardiology
Commentary
03/31/2010
P. Syamasundar Rao, MD, FACC; Duraisamy Balaguru, MD
Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their...
Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their...
Several devices have been...
03/31/2010
Journal of Invasive Cardiology
Tips and Techniques
04/01/2010
Benjamin Farber, MD; Amiram Nir, MD; David Meerkin, MBBS, MD
ABSTRACT: Background. The recently released Amplatzer Ductal Occluder 2 (ADO2) was designed specifically for use in small children with moderate-sized shunts and larger children with small patent ductus arterioses (PDA). We report our initial...
ABSTRACT: Background. The recently released Amplatzer Ductal Occluder 2 (ADO2) was designed specifically for use in small children with moderate-sized shunts and larger children with small patent ductus arterioses (PDA). We report our initial...
ABSTRACT: Background. The...
04/01/2010
Journal of Invasive Cardiology
Clinical Images
04/01/2010
James J. Jang, MD; Kenneth S. Battaglia, MD; Valerie C. Kwai Ben, MD
ABSTRACT: We present the case of a 54-year-old male with a St. Jude aortic valve replacement who presented with fever and a new diastolic murmur. An echocardiogram identified a pseudoaneurysm that appeared to originate from the left sinus of...
ABSTRACT: We present the case of a 54-year-old male with a St. Jude aortic valve replacement who presented with fever and a new diastolic murmur. An echocardiogram identified a pseudoaneurysm that appeared to originate from the left sinus of...
ABSTRACT: We present the case of...
04/01/2010
Journal of Invasive Cardiology
